Term: | fulvestrant |
|
Accession: | CHEBI:31638
|
browse the term
|
Definition: | A 3-hydroxy steroid that is 17beta-estradiol in which the 7alpha hydrogen has been replaced by a nonyl group in which one of the hydrogens of the terminal methyl has been replaced by a (4,4,5,5,5-pentafluoropentyl)sulfinyl group. An estrogen receptor antagonist, it is used in the treatment of breast cancer. |
Synonyms: | exact_synonym: | 7alpha-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17beta-diol |
| related_synonym: | (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17-diol; Faslodex; Formula=C32H47F5O3S; ICI-182780; InChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29?,30+,41?/m1/s1; InChIKey=VWUXBMIQPBEWFH-WCCTWKNTSA-N; SMILES=C=1C=C(C=C2C1[C@]3(CC[C@@]4([C@H](CC[C@]4([C@@]3([C@@H](C2)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F)[H])[H])O)C)[H])O; fulvestrantum |
| alt_id: | CHEBI:87729 |
| xref: | CAS:129453-61-8; DrugBank:DB00947; Drug_Central:1255; KEGG:D01161; LINCS:LSM-6504 |
| xref_mesh: | MESH:C070081 |
| xref: | PMID:18683044; PMID:19369092; PMID:21319872; PMID:21699443; PMID:25720568; Wikipedia:Fulvestrant |
|
|